Clinical Stage Biotechs For Sale?
This article was originally published in The Pink Sheet Daily
Executive Summary
The oversized price tag attached to the recent acquisition of Pharmasset by Gilead has caused many to wonder how the take-out fits into historical patterns – or if it’s as big an outlier as it seems.